Bastei Lübbe AG / Key word(s): IPO 27.09.2013 15:35 Dissemination of an Ad hoc announcement according to § 15 WpHG, transmitted by DGAP - a company of EQS Group AG. The issuer is solely responsible for the content of this announcement. --------------------------------------------------------------------------- Publication of an Ad hoc announcement according to Para. 15 WpHG, transmitted by DGAP - a company of EQS Group AG. The issuer is solely responsible for the content of this announcement. Bastei Lübbe AG lowers the price range and extends the subscription period by one day Cologne, 27 September 2013 - Bastei Lübbe AG lowers the price range for the shares currently offered in a public offering to EUR 7.50 - 9.00 per share. Interested investors now have the opportunity to subscribe until 2 October 2013. Shares may be subscribed to by investors either through their bank or directly over the Deutsche Börse (German Stock Exchange) in Frankfurt. Subscriptions which have already been submitted are still valid and will be considered based on the reduced price range, unless investors make use of their granted right to withdraw their subscription within two working days after the publication of the supplement to the prospectus, which includes the change in the price range. Up to 5,300,000 no par value ordinary bearer shares with no par value (shares) with a proportionate amount of the share capital of EUR 1.00 per share are being offered. Of these, up to 3,300,000 million shares from a capital increase in Bastei Lübbe AG, which would raise the share capital of EUR 10,000,000.00 to up to EUR 13,300,000.00. The remaining 2,000,000 shares are offered as part of a placement and a possible over-allotment option from the share holdings of Lübbe Beteiligungs-GmbH. Consequently, a gross offering size of up to EUR47.7 million is anticipated. In the Company's view, the reduction of the price range has no adverse change in the planned strategic investments which should be financed from the proceeds of the capital increase. The use of proceeds will focus on intensifying the development of own content as well as on the planned digitalization and globalization of content and brands. The offering terms and conditions originate from the Federal Financial Supervisory Authority (BaFin) approved prospectus and the still to be approved and not yet published supplement to the prospectus. About Bastei Lübbe AG Bastei Lübbe AG is a German publishing and media group long renowned for bringing popular fiction as well as non-fiction to the mass market. Its business activities include not only paperback and hardback books in print form but also audiobooks, e-books, and other digital publications. Its catalogue includes a wide range of fiction, non-fiction and entertainment products intended for a wide readership, including not only the various highly successful paperback fiction series for which Bastei Lübbe has long been famed but also puzzle books and magazines. The group's business activities additionally include the licensing of book rights and the creation, production and marketing of gift, decorative and merchandising articles. Bastei Lübbe also owns the following non-consolidated shareholdings in companies: 90% of Moravská Bastei MOBA, s.r.o. (Brno, Czech Republic), 100% of Bastei Media GmbH (Erfurt, Germany), 50% of PR�SENTA PROMOTION INTERNATIONAL GmbH (Solingen, Germany), and 100% of Bastei Lübbe Verwaltungs GmbH (Cologne, Germany). The company also has smaller shareholdings in various book and periodical distribution companies, none of which exceeds 5% of the respective company's registered capital. The business activities of Bastei Lübbe are broadly divided into segments: Books, Non-Books, and Popular Fiction and Puzzle Publications, which in turn include various product areas. The group publishes under 13 different labels, which span its full range of market segments and product areas. For the fiscal year 2012/2013, 80% of the group's revenues were derived from the Books segment, while 11% came from Non-Books and the remaining 9% from Popular Fiction and Puzzle Publications. At the end of its fiscal year 2012/2013, the number of staff employed by Bastei Lübbe was 265, compared to 210 at the close of the prior fiscal year. These figures do not include the 15 staff employed by its non-consolidated subsidiary Moravská Bastei MOBA, s.r.o. (Brno, Czech Republic), or at its other non-consolidated subsidiaries and affiliates (Bastei Media GmbH and PR�SENTA PROMOTION INTERNATIONAL GmbH). As of the date of the offering prospectus, the number of staff was 305, a further increase since the end of fiscal year 2012/2013. Disclaimer This publication and the information contained therein do not constitute an offer to sell or a solicition of an offer to buy or subscribe for securities of Bastei Lübbe AG. There will be no public offering of securities of Bastei Lübbe AG outside Germany, Austria and Luxembourg. The public offering in Germany, Austria and Luxembourg is being made exclusively on the basis of the securities prospectus (including any supplements thereto), which has been approved by the Bundesanstalt für Finanzdienstleistungsaufsicht (BaFin) and which has been notified to the responsible authorities in Austria and Luxembourg. The prospectus (including any supplements thereto) is available on the website of Bastei Lübbe AG (www.lübbe.de) and at the company (Schanzenstra�e 6 - 20, 51063 Köln) and is the sole commanding document for the offering. Any decision by investors to invest in shares of Bastei Lübbe AG should be made exclusively on the basis of the prospectus (including any supplements thereto). Barbara Fischer Head of Public Relations Tel.: 0049 (0)221 82 00 28 50 E-Mail: barbara.fischer@luebbe.de 27.09.2013 DGAP's Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de --------------------------------------------------------------------------- Language: English Company: Bastei Lübbe AG Schanzenstra�e 6 - 20 51063 Köln Germany Phone: 02 21 / 82 00 - 0 Fax: 02 21 / 82 00 - 1900 E-mail: investorrelations@luebbe.de Internet: www.luebbe.de ISIN: DE000A1X3YY0, DE000A1K0169 WKN: A1X3YY, A1K016 Listed: Regulierter Markt in Frankfurt (Prime Standard) Notierung vorgesehen / intended to be listed End of Announcement DGAP News-Service ---------------------------------------------------------------------------
DGAP-Adhoc: Bastei Lübbe AG: Publication of an Ad hoc
Top 10 Most Recent News Articles
Phase I of 2026 Hong Kong Trade Shows Highlights Innovation
Hong Kong Takes Center Stage in Global Commerce Flip through the economic landscape today, and you’ll spot Hong Kong, decked out in its best as a trade linchpin—with over 2,100 suppliers gathered under one roof. AsiaWorld-Expo is buzzing with the commencement of Phase I of the October 2026 Global Sources Hong Kong Shows. The theme's all about 'Connecting Global...
Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data
Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...
Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight
A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...
Continue Reading
NARUTO Card Game Set for June 2027 Global Launch
Mark Your Calendars: Global Launch June 2027 They're rolling out a red carpet for nostalgia here, I tell ya! At the New York Comic Con, BANDAI announced a worldwide launch for the NARUTO CARD GAME in June 2027. We'll see pre-built decks starring your favorite shinobi and a mad sprint to collect with the new booster packs. Feels sort of like they’re summoning a jutsu...
Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight
First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...
Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps
Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...
Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal
A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...
Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity
Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...
Continue Reading
AI Drives Major Time Savings in Endoscopy Tech
AI in Endoscopy: Game-Changer or Gimmick? Stumbling across AnX Robotica's latest pitch about their NaviCam ProScan AI workflow, one can't help but feel a mix of curiosity and skepticism. With the stakes in medical tech sky-high, they've fired off some impressive stats that grab attention. We're talking about cutting small-bowel capsule review times by a whopping...
Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances
A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...
Continue ReadingTop 5 Most Recently Viewed Articles
Chart Industries Transitions to New Leadership in Upcoming Merger
Chart Industries Announces Leadership Change Chart Industries (NYSE: GTLS) is taking significant steps toward a future transition as CEO Jill Evanko has announced plans to assume a senior advisor role starting in early 2026. This change comes as she prepares to take on a new executive opportunity within a privately owned company. Evanko has been essential in steering the...
Continue Reading
Understanding Debtors: Insights into Realkredit Danmark A/S
Understanding Debtors: Key Insights from Realkredit Danmark A/S At the heart of any effective financial institution is a reliable understanding of its debtors. Realkredit Danmark A/S, a prestigious name in the financial landscape, recently made available a detailed breakdown of its debtors. This information is crucial for various stakeholders, including investors,...
Continue Reading
Cryptocurrency Market Update: Bitcoin Droops under $59K with ETF Inflows Soaring
Bitcoin's Recent Performance The cryptocurrency market has been lively lately, especially with Bitcoin recently falling below the $59,000 threshold. Investors had been optimistic, especially since the cryptocurrency saw a remarkable $436 million in net ETF inflows just last week. This significant influx signals that institutional interest in cryptocurrencies is still...
Continue Reading
Enhancing Specialized Care for ARFID Treatment with Emily Program
Introduction to The Emily Program and ARFID The Emily Program is making significant strides in specialized care for individuals with Avoidant/Restrictive Food Intake Disorder (ARFID). This condition, often misunderstood, has recently begun to garner more attention from healthcare experts. In response to this need, The Emily Program is offering advanced treatment...
Continue Reading
Investigation of Alleged Securities Fraud at 3D Systems Unfolds
Overview of Legal Actions Against 3D Systems Corporation Recently, investors in 3D Systems Corporation have found themselves entangled in a potential securities fraud lawsuit. This case serves as a cautionary tale, highlighting the importance of transparency and integrity in corporate communication. The allegations stem from assertions that the company made misleading...
Continue Reading